| Cas No.: | 2031177-48-5 |
| Synonyms: | ZM223,ZM-223,ZM 223 |
| SMILES: | O=C(C1=CC=C(C(F)(F)F)C=C1)NC2=NC3=CC=C(NC(CSC4=CC=C(N)C=C4)=O)C=C3S2 |
| Formula: | C23H17F3N4O2S2 |
| M.Wt: | 502.53 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | ZM223 is a novel non-sulfamide NEDD8 activating enzyme inhibitor that inhibits HCT116 colon cancer cells with an IC50 value of 100 nM. |
| Target: | IC50: 100 nM (HCT116), 122 nM (U-2OS)[1] |
| In Vitro: | ZM223 exhibits excellent antitumor activities against both HCT116 and U-2OS cells (IC50=100, 122 nM)[1]. Western Blot Analysis[1] Cell Line: HCT-116 cells Concentration: 0.1, 1 μM Incubation Time: 4 hours Result: ZM223 inhibited NEDD8 protein and subsequently elevated UBC12 level[1]. |
| References: | [1]. Ma H, et al. Discovery of benzothiazole derivatives as novel non-sulfamide NEDD8 activating enzyme inhibitors by target-based virtual screening. Eur J Med Chem. 2017 Jun 16;133:174-183. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
